Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults
Public ClinicalTrials.gov record NCT02071082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Open-label Study of the Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the efficacy, safety, and tolerability of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) coinfected adults. Participants will be enrolled into two cohorts: * Cohort 1: HIV/HBV coinfected adults who are HIV treatment-naive and HBV treatment-naive * Cohort 2: HIV/HBV coinfected adults who are HIV-suppressed
Study identification
- NCT ID
- NCT02071082
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 79 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2014
- Primary completion
- Jan 22, 2015
- Completion
- Oct 25, 2016
- Last update posted
- Nov 15, 2018
2014 – 2016
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Spectrum Medical Group | Phoenix | Arizona | 85012 | — |
| AHF Research Center | Beverly Hills | California | 90211 | — |
| Peter J. Ruane MD, Inc. | Los Angeles | California | 90036 | — |
| Anthony Mills MD, Inc | Los Angeles | California | 90069 | — |
| Whitman Walker Health | Washington D.C. | District of Columbia | 20009 | — |
| Barry M. Rodwick MD | Clearwater | Florida | 33765 | — |
| Gary J Richmond M.D.,P.A. | Fort Lauderdale | Florida | 33316 | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | 34982 | — |
| AIDS Health Foundation/WPA | Miami Beach | Florida | 33139 | — |
| AIDS Research and Treatment Center of the Treasure Coast | Vero Beach | Florida | 32960 | — |
| Triple O Research Institute PA | West Palm Beach | Florida | 33401 | — |
| Be Well Medical Center PC | Berkley | Michigan | 48072 | — |
| KC Care Clinic | Kansas City | Missouri | 64111 | — |
| Southampton Healthcare, Inc. | St Louis | Missouri | 63139 | — |
| Southwest CARE Center | Santa Fe | New Mexico | 87505 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| St. Hope Foundation | Bellaire | Texas | — | — |
| North Texas Infectious Diseases Consultants | Dallas | Texas | 75246 | — |
| Therapeutic Concepts | Houston | Texas | 77004 | — |
| Gordon E. Crofoot MD PA | Houston | Texas | 77098 | — |
| Peter Shalit MD | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02071082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2018 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02071082 live on ClinicalTrials.gov.